You are here: Industry Insights > Market News > Putin Says Russia Continues Working on New Vaccines, Medication for Treating COVID-19

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Putin Says Russia Continues Working on New Vaccines, Medication for Treating COVID-19

firstwordpharmaJune 21, 2021

Tag: Putin , vaccines , COVID-19

Favorites

Russian President Vladimir Putin congratulated medical workers on Medical Worker Day, thanking them for their efforts in the fight against COVID-19 and calling for a more active vaccination programme, as reported Sputnik.

Putin Says Russia Continues Working on New Vaccines, Medication for Treating COVID-19

"It is imperative to step up the vaccination rates. We have all we need to do this. Russia has four coronavirus vaccines of its own, and new vaccines and medications are under development," Putin said.

Previous:Urgently trying to work with AstraZeneca, SII, Indian govt to resume shipments of COVID-19 vaccines: WHO

Next:China, Other Asian Countries Vaccinate Against Covid-19 Faster Than Ever

New CRO Focused on Cannabis-based Drug Trials Launched

Biotech NewswireMay 23, 2024

Cannovation Clinical Research Partners takes a holistic approach to assist businesses throughout the entire product lifecycle, encompassing product development, commercialization, and launch phases.

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

PharmaSourcesMay 21, 2024

Selection of Commercial Models for Innovative Drugs

PharmaSourcesMay 21, 2024

Putin Says Russia Continues Working on New Vaccines, Medication for Treating COVID-19 | Pharmasources.com

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.

Putin Says Russia Continues Working on New Vaccines, Medication for Treating COVID-19

Related News

New CRO Focused on Cannabis-based Drug Trials Launched

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

Selection of Commercial Models for Innovative Drugs

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

You may like